Pharma & Healthcare

Global Drugs based on Genetic Engineering Market Research Report 2025

The global market for Drugs based on Genetic Engineering was valued at US$ 314526 million in the year 2024 and is projected to reach a revised size of US$ 487657 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Drugs based on genetic engineering are pharmaceutical products developed using biotechnology techniques such as recombinant DNA technology, gene editing, or synthetic biology. These drugs are typically proteins, peptides, nucleic acids, or living cells that are designed to prevent, treat, or cure diseases by modifying or influencing genetic or molecular pathways in the body.
North American market for Drugs based on Genetic Engineering is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drugs based on Genetic Engineering is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drugs based on Genetic Engineering in Cancers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drugs based on Genetic Engineering include Novo Nordisk, Amgen, Eli Lilly, Sanofi, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, AbbVie, Sandoz, Biogen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drugs based on Genetic Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs based on Genetic Engineering.
The Drugs based on Genetic Engineering market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs based on Genetic Engineering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs based on Genetic Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Amgen
Eli Lilly
Sanofi
Bayer
Bristol-Myers Squibb
GlaxoSmithKline
AbbVie
Sandoz
Biogen
Pfizer
GenSci
3SBIO
Organon Pharma
Roche
Swedish Orphan Biovitrum
CSPC
Johnson & Johnson
Merck
Takeda
Segment by Type
Fusion Protein
Recombinant Growth Factor
Recombinant Hormone
Recombinant Interferon
Recombinant Interleukin
Recombinant Coagulation Factor
Other
Segment by Application
Cancers
Autoimmune Diseases
Metabolic Disorders
Infectious Diseases
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs based on Genetic Engineering company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs based on Genetic Engineering Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fusion Protein
1.2.3 Recombinant Growth Factor
1.2.4 Recombinant Hormone
1.2.5 Recombinant Interferon
1.2.6 Recombinant Interleukin
1.2.7 Recombinant Coagulation Factor
1.2.8 Other
1.3 Market by Application
1.3.1 Global Drugs based on Genetic Engineering Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancers
1.3.3 Autoimmune Diseases
1.3.4 Metabolic Disorders
1.3.5 Infectious Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs based on Genetic Engineering Market Perspective (2020-2031)
2.2 Global Drugs based on Genetic Engineering Growth Trends by Region
2.2.1 Global Drugs based on Genetic Engineering Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs based on Genetic Engineering Historic Market Size by Region (2020-2025)
2.2.3 Drugs based on Genetic Engineering Forecasted Market Size by Region (2026-2031)
2.3 Drugs based on Genetic Engineering Market Dynamics
2.3.1 Drugs based on Genetic Engineering Industry Trends
2.3.2 Drugs based on Genetic Engineering Market Drivers
2.3.3 Drugs based on Genetic Engineering Market Challenges
2.3.4 Drugs based on Genetic Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs based on Genetic Engineering Players by Revenue
3.1.1 Global Top Drugs based on Genetic Engineering Players by Revenue (2020-2025)
3.1.2 Global Drugs based on Genetic Engineering Revenue Market Share by Players (2020-2025)
3.2 Global Top Drugs based on Genetic Engineering Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs based on Genetic Engineering Revenue
3.4 Global Drugs based on Genetic Engineering Market Concentration Ratio
3.4.1 Global Drugs based on Genetic Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs based on Genetic Engineering Revenue in 2024
3.5 Global Key Players of Drugs based on Genetic Engineering Head office and Area Served
3.6 Global Key Players of Drugs based on Genetic Engineering, Product and Application
3.7 Global Key Players of Drugs based on Genetic Engineering, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs based on Genetic Engineering Breakdown Data by Type
4.1 Global Drugs based on Genetic Engineering Historic Market Size by Type (2020-2025)
4.2 Global Drugs based on Genetic Engineering Forecasted Market Size by Type (2026-2031)
5 Drugs based on Genetic Engineering Breakdown Data by Application
5.1 Global Drugs based on Genetic Engineering Historic Market Size by Application (2020-2025)
5.2 Global Drugs based on Genetic Engineering Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs based on Genetic Engineering Market Size (2020-2031)
6.2 North America Drugs based on Genetic Engineering Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs based on Genetic Engineering Market Size by Country (2020-2025)
6.4 North America Drugs based on Genetic Engineering Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs based on Genetic Engineering Market Size (2020-2031)
7.2 Europe Drugs based on Genetic Engineering Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs based on Genetic Engineering Market Size by Country (2020-2025)
7.4 Europe Drugs based on Genetic Engineering Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drugs based on Genetic Engineering Market Size (2020-2031)
8.2 Asia-Pacific Drugs based on Genetic Engineering Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs based on Genetic Engineering Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs based on Genetic Engineering Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drugs based on Genetic Engineering Market Size (2020-2031)
9.2 Latin America Drugs based on Genetic Engineering Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs based on Genetic Engineering Market Size by Country (2020-2025)
9.4 Latin America Drugs based on Genetic Engineering Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs based on Genetic Engineering Market Size (2020-2031)
10.2 Middle East & Africa Drugs based on Genetic Engineering Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs based on Genetic Engineering Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs based on Genetic Engineering Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Drugs based on Genetic Engineering Introduction
11.1.4 Novo Nordisk Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.1.5 Novo Nordisk Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Drugs based on Genetic Engineering Introduction
11.2.4 Amgen Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drugs based on Genetic Engineering Introduction
11.3.4 Eli Lilly Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Drugs based on Genetic Engineering Introduction
11.4.4 Sanofi Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Drugs based on Genetic Engineering Introduction
11.5.4 Bayer Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Drugs based on Genetic Engineering Introduction
11.6.4 Bristol-Myers Squibb Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Drugs based on Genetic Engineering Introduction
11.7.4 GlaxoSmithKline Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Drugs based on Genetic Engineering Introduction
11.8.4 AbbVie Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Sandoz
11.9.1 Sandoz Company Details
11.9.2 Sandoz Business Overview
11.9.3 Sandoz Drugs based on Genetic Engineering Introduction
11.9.4 Sandoz Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.9.5 Sandoz Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Drugs based on Genetic Engineering Introduction
11.10.4 Biogen Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.10.5 Biogen Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Drugs based on Genetic Engineering Introduction
11.11.4 Pfizer Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 GenSci
11.12.1 GenSci Company Details
11.12.2 GenSci Business Overview
11.12.3 GenSci Drugs based on Genetic Engineering Introduction
11.12.4 GenSci Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.12.5 GenSci Recent Development
11.13 3SBIO
11.13.1 3SBIO Company Details
11.13.2 3SBIO Business Overview
11.13.3 3SBIO Drugs based on Genetic Engineering Introduction
11.13.4 3SBIO Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.13.5 3SBIO Recent Development
11.14 Organon Pharma
11.14.1 Organon Pharma Company Details
11.14.2 Organon Pharma Business Overview
11.14.3 Organon Pharma Drugs based on Genetic Engineering Introduction
11.14.4 Organon Pharma Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.14.5 Organon Pharma Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Drugs based on Genetic Engineering Introduction
11.15.4 Roche Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.15.5 Roche Recent Development
11.16 Swedish Orphan Biovitrum
11.16.1 Swedish Orphan Biovitrum Company Details
11.16.2 Swedish Orphan Biovitrum Business Overview
11.16.3 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Introduction
11.16.4 Swedish Orphan Biovitrum Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.16.5 Swedish Orphan Biovitrum Recent Development
11.17 CSPC
11.17.1 CSPC Company Details
11.17.2 CSPC Business Overview
11.17.3 CSPC Drugs based on Genetic Engineering Introduction
11.17.4 CSPC Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.17.5 CSPC Recent Development
11.18 Johnson & Johnson
11.18.1 Johnson & Johnson Company Details
11.18.2 Johnson & Johnson Business Overview
11.18.3 Johnson & Johnson Drugs based on Genetic Engineering Introduction
11.18.4 Johnson & Johnson Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.18.5 Johnson & Johnson Recent Development
11.19 Merck
11.19.1 Merck Company Details
11.19.2 Merck Business Overview
11.19.3 Merck Drugs based on Genetic Engineering Introduction
11.19.4 Merck Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.19.5 Merck Recent Development
11.20 Takeda
11.20.1 Takeda Company Details
11.20.2 Takeda Business Overview
11.20.3 Takeda Drugs based on Genetic Engineering Introduction
11.20.4 Takeda Revenue in Drugs based on Genetic Engineering Business (2020-2025)
11.20.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs based on Genetic Engineering Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fusion Protein
Table 3. Key Players of Recombinant Growth Factor
Table 4. Key Players of Recombinant Hormone
Table 5. Key Players of Recombinant Interferon
Table 6. Key Players of Recombinant Interleukin
Table 7. Key Players of Recombinant Coagulation Factor
Table 8. Key Players of Other
Table 9. Global Drugs based on Genetic Engineering Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Drugs based on Genetic Engineering Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Drugs based on Genetic Engineering Market Share by Region (2020-2025)
Table 13. Global Drugs based on Genetic Engineering Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Drugs based on Genetic Engineering Market Share by Region (2026-2031)
Table 15. Drugs based on Genetic Engineering Market Trends
Table 16. Drugs based on Genetic Engineering Market Drivers
Table 17. Drugs based on Genetic Engineering Market Challenges
Table 18. Drugs based on Genetic Engineering Market Restraints
Table 19. Global Drugs based on Genetic Engineering Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Drugs based on Genetic Engineering Market Share by Players (2020-2025)
Table 21. Global Top Drugs based on Genetic Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs based on Genetic Engineering as of 2024)
Table 22. Ranking of Global Top Drugs based on Genetic Engineering Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Drugs based on Genetic Engineering Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Drugs based on Genetic Engineering, Headquarters and Area Served
Table 25. Global Key Players of Drugs based on Genetic Engineering, Product and Application
Table 26. Global Key Players of Drugs based on Genetic Engineering, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Drugs based on Genetic Engineering Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Drugs based on Genetic Engineering Revenue Market Share by Type (2020-2025)
Table 30. Global Drugs based on Genetic Engineering Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Drugs based on Genetic Engineering Revenue Market Share by Type (2026-2031)
Table 32. Global Drugs based on Genetic Engineering Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Drugs based on Genetic Engineering Revenue Market Share by Application (2020-2025)
Table 34. Global Drugs based on Genetic Engineering Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Drugs based on Genetic Engineering Revenue Market Share by Application (2026-2031)
Table 36. North America Drugs based on Genetic Engineering Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Drugs based on Genetic Engineering Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Drugs based on Genetic Engineering Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Drugs based on Genetic Engineering Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Drugs based on Genetic Engineering Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Drugs based on Genetic Engineering Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Drugs based on Genetic Engineering Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Drugs based on Genetic Engineering Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Drugs based on Genetic Engineering Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Drugs based on Genetic Engineering Market Size by Country (2026-2031) & (US$ Million)
Table 51. Novo Nordisk Company Details
Table 52. Novo Nordisk Business Overview
Table 53. Novo Nordisk Drugs based on Genetic Engineering Product
Table 54. Novo Nordisk Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 55. Novo Nordisk Recent Development
Table 56. Amgen Company Details
Table 57. Amgen Business Overview
Table 58. Amgen Drugs based on Genetic Engineering Product
Table 59. Amgen Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 60. Amgen Recent Development
Table 61. Eli Lilly Company Details
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Drugs based on Genetic Engineering Product
Table 64. Eli Lilly Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Drugs based on Genetic Engineering Product
Table 69. Sanofi Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Drugs based on Genetic Engineering Product
Table 74. Bayer Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Bristol-Myers Squibb Company Details
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb Drugs based on Genetic Engineering Product
Table 79. Bristol-Myers Squibb Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 80. Bristol-Myers Squibb Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Drugs based on Genetic Engineering Product
Table 84. GlaxoSmithKline Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Drugs based on Genetic Engineering Product
Table 89. AbbVie Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Sandoz Company Details
Table 92. Sandoz Business Overview
Table 93. Sandoz Drugs based on Genetic Engineering Product
Table 94. Sandoz Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 95. Sandoz Recent Development
Table 96. Biogen Company Details
Table 97. Biogen Business Overview
Table 98. Biogen Drugs based on Genetic Engineering Product
Table 99. Biogen Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Drugs based on Genetic Engineering Product
Table 104. Pfizer Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. GenSci Company Details
Table 107. GenSci Business Overview
Table 108. GenSci Drugs based on Genetic Engineering Product
Table 109. GenSci Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 110. GenSci Recent Development
Table 111. 3SBIO Company Details
Table 112. 3SBIO Business Overview
Table 113. 3SBIO Drugs based on Genetic Engineering Product
Table 114. 3SBIO Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 115. 3SBIO Recent Development
Table 116. Organon Pharma Company Details
Table 117. Organon Pharma Business Overview
Table 118. Organon Pharma Drugs based on Genetic Engineering Product
Table 119. Organon Pharma Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 120. Organon Pharma Recent Development
Table 121. Roche Company Details
Table 122. Roche Business Overview
Table 123. Roche Drugs based on Genetic Engineering Product
Table 124. Roche Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 125. Roche Recent Development
Table 126. Swedish Orphan Biovitrum Company Details
Table 127. Swedish Orphan Biovitrum Business Overview
Table 128. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product
Table 129. Swedish Orphan Biovitrum Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 130. Swedish Orphan Biovitrum Recent Development
Table 131. CSPC Company Details
Table 132. CSPC Business Overview
Table 133. CSPC Drugs based on Genetic Engineering Product
Table 134. CSPC Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 135. CSPC Recent Development
Table 136. Johnson & Johnson Company Details
Table 137. Johnson & Johnson Business Overview
Table 138. Johnson & Johnson Drugs based on Genetic Engineering Product
Table 139. Johnson & Johnson Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 140. Johnson & Johnson Recent Development
Table 141. Merck Company Details
Table 142. Merck Business Overview
Table 143. Merck Drugs based on Genetic Engineering Product
Table 144. Merck Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 145. Merck Recent Development
Table 146. Takeda Company Details
Table 147. Takeda Business Overview
Table 148. Takeda Drugs based on Genetic Engineering Product
Table 149. Takeda Revenue in Drugs based on Genetic Engineering Business (2020-2025) & (US$ Million)
Table 150. Takeda Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report


List of Figures
Figure 1. Drugs based on Genetic Engineering Picture
Figure 2. Global Drugs based on Genetic Engineering Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs based on Genetic Engineering Market Share by Type: 2024 VS 2031
Figure 4. Fusion Protein Features
Figure 5. Recombinant Growth Factor Features
Figure 6. Recombinant Hormone Features
Figure 7. Recombinant Interferon Features
Figure 8. Recombinant Interleukin Features
Figure 9. Recombinant Coagulation Factor Features
Figure 10. Other Features
Figure 11. Global Drugs based on Genetic Engineering Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Drugs based on Genetic Engineering Market Share by Application: 2024 VS 2031
Figure 13. Cancers Case Studies
Figure 14. Autoimmune Diseases Case Studies
Figure 15. Metabolic Disorders Case Studies
Figure 16. Infectious Diseases Case Studies
Figure 17. Drugs based on Genetic Engineering Report Years Considered
Figure 18. Global Drugs based on Genetic Engineering Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Drugs based on Genetic Engineering Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Drugs based on Genetic Engineering Market Share by Region: 2024 VS 2031
Figure 21. Global Drugs based on Genetic Engineering Market Share by Players in 2024
Figure 22. Global Drugs based on Genetic Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Drugs based on Genetic Engineering Revenue in 2024
Figure 24. North America Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Drugs based on Genetic Engineering Market Share by Country (2020-2031)
Figure 26. United States Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Drugs based on Genetic Engineering Market Share by Country (2020-2031)
Figure 30. Germany Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Drugs based on Genetic Engineering Market Share by Region (2020-2031)
Figure 38. China Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Drugs based on Genetic Engineering Market Share by Country (2020-2031)
Figure 46. Mexico Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Drugs based on Genetic Engineering Market Share by Country (2020-2031)
Figure 50. Israel Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Drugs based on Genetic Engineering Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Novo Nordisk Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 55. Eli Lilly Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 57. Bayer Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 60. AbbVie Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 61. Sandoz Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 62. Biogen Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 63. Pfizer Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 64. GenSci Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 65. 3SBIO Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 66. Organon Pharma Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 67. Roche Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 68. Swedish Orphan Biovitrum Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 69. CSPC Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 70. Johnson & Johnson Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 71. Merck Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 72. Takeda Revenue Growth Rate in Drugs based on Genetic Engineering Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies